ULTRASOUND-GUIDED SALIVARY GLAND BOTULINUM TOXIN FOR CHRONIC SIALORRHEA IN OTOLARYNGOLOGY: PROCEDURAL TECHNOLOGY, SERVICE DELIVERY, AND PUBLIC HEALTH OUTCOMES
Authors:
Open Access
- 30 March 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (1(49))
Abstract
Chronic sialorrhea has consequences that extend far beyond visible drooling. In otolaryngology practice it can affect airway protection, skin integrity, communication, feeding routines, social participation, school or work functioning, and unpaid caregiver time. This review synthesizes PubMed-indexed evidence on salivary gland botulinum toxin with particular attention to how imaging support, care setting, and service organization shape clinical and public-health outcomes. PubMed was used as the core database for a structured narrative search completed on March 12, 2026, and evidence was synthesized thematically, prioritizing randomized trials, systematic reviews, consensus documents, and larger cohort studies. Across adult and pediatric populations, botulinum toxin consistently reduces drooling severity in appropriately selected patients, while ultrasound guidance improves localization confidence and supports more reproducible, teachable protocols. The major unresolved questions concern optimal gland combinations, formulation-specific dose strategies, longer-term respiratory outcomes, comparative costs across settings, and equitable access for medically underserved populations. Current evidence supports botulinum toxin as a minimally invasive component of stepwise drooling management when paired with structured swallowing assessment, caregiver-centered outcomes, and implementation models that reduce avoidable anesthesia exposure and travel burden.Keywords
This publication has 15 references indexed in Scilit:
- Botox injections with and without general anesthesia for pediatric sialorrhea: A cost, efficacy, and safety analysisInternational Journal of Pediatric Otorhinolaryngology, 2025
- Interdisciplinary assessment and treatment of paediatric drooling: two decades of experience by the Nijmegen saliva control team reflected in a stepwise algorithmEuropean Journal of Pediatrics, 2024
- Comprehensive management of anterior drooling: An International Pediatric Otolaryngology Group (IPOG) consensus statementInternational Journal of Pediatric Otorhinolaryngology, 2023
- Treatment of sialorrhea with botulinum toxin injections in pediatric patients less than three years of ageInternational Journal of Pediatric Otorhinolaryngology, 2022
- Drooling outcome measures in paediatric disability: a systematic reviewEuropean Journal of Pediatrics, 2022
- Cost‐effectiveness of botulinum neurotoxin A versus surgery for drooling: a randomized clinical trialDevelopmental Medicine & Child Neurology, 2020
- Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeksParkinsonism & Related Disorders, 2020
- Localization of Salivary Glands for Botulinum Toxin Treatment: Ultrasound Versus Landmark GuidanceMovement Disorders Clinical Practice, 2019
- Ultrasound-Guided Botulinum Toxin Type A Salivary Gland Injection in Children for Refractory Sialorrhea: 10-Year Experience at a Large Tertiary Children's HospitalPediatric Neurology, 2016
- Salivary botulinum toxin injection may reduce aspiration pneumonia in neurologically impaired childrenInternational Journal of Pediatric Otorhinolaryngology, 2015